• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲癌症研究与治疗组织(EORTC)QLQ - C30身体、角色、社会和情感功能、疲劳及总体健康状况/生活质量量表与相应的患者报告结果测量信息系统(PROMIS)量表之间的转换关系的建立与验证。

Development and validation of crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/quality of life scales and their corresponding PROMIS scales.

作者信息

Oerlemans Simone, Lodder Paul, van der Baan Frederieke, Giesinger Johannes M, Ezendam Nicole P M

机构信息

Department of Research and development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; Department of Methodology and Statistics, Tilburg University, Tilburg, The Netherlands.

出版信息

J Clin Epidemiol. 2025 May 29;184:111853. doi: 10.1016/j.jclinepi.2025.111853.

DOI:10.1016/j.jclinepi.2025.111853
PMID:40447202
Abstract

OBJECTIVES

Across patient-reported outcome measures (PROMs), the European Organization of Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is one of the most widely used among patients with cancer. Patients may also complete other PROMs such as forms of the Patient-Reported Outcomes Measurement Information System (PROMIS). The objective of this study was to develop crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/quality of life (QoL) scales and their corresponding PROMIS scales.

STUDY DESIGN AND SETTING

In a single group-design, using the Netherlands Patient-Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship (PROFILES) registry, patients of various cancers were invited to complete the EORTC QLQ-C30 and PROMIS forms from September to December 2022. Data were randomly divided into a calibration and validation set. Crosswalks were developed using equipercentile equating and their predictive performance was assessed in terms of standardized mean absolute errors (SMAEs) and intraclass correlations (ICCs).

RESULTS

The total sample consisted of 1972 cancer patients (mean age 61 years; 55% female). We developed 15 crosswalks. Their SMAE was generally satisfactory (below 0.50) and comparable in the calibration and validation datasets. The highest precision was found for the physical functioning and fatigue crosswalks, followed by role functioning, emotional functioning and depression. The lowest precision was found for the EORTC QLQ-C30 to PROMIS general health, general QoL, and anxiety scores. Almost all ICC were above 0.70, except for EORTC QLQ-C30 to PROMIS anxiety/depression and PROMIS to EORTC social functioning.

CONCLUSION

We developed valid crosswalks for multiple scales of the EORTC QLQ-C30 and PROMIS. The established concordance tables can be used to convert scores in both directions and are valid for group level analyses. The crosswalks from EORTC emotional functioning toward PROMIS anxiety and depression demonstrate suboptimal performance and should therefore be used carefully.

摘要

目的

在患者报告结局指标(PROMs)中,欧洲癌症研究与治疗组织生活质量问卷核心30项(EORTC QLQ-C30)是癌症患者中使用最广泛的指标之一。患者也可能会完成其他PROMs,如患者报告结局测量信息系统(PROMIS)的各种形式。本研究的目的是建立EORTC QLQ-C30的身体、角色、社会和情感功能、疲劳以及总体健康状况/生活质量(QoL)量表与其相应PROMIS量表之间的转换关系。

研究设计与设置

采用单组设计,利用荷兰初始治疗后患者报告结局及幸存者长期评估(PROFILES)登记库,邀请各类癌症患者在2022年9月至12月期间完成EORTC QLQ-C30和PROMIS表格。数据被随机分为校准集和验证集。使用等百分位等值法建立转换关系,并根据标准化平均绝对误差(SMAEs)和组内相关系数(ICCs)评估其预测性能。

结果

总样本包括1972名癌症患者(平均年龄61岁;55%为女性)。我们建立了15种转换关系。它们的SMAE总体上令人满意(低于0.50),在校准集和验证数据集中相当。身体功能和疲劳转换关系的精度最高,其次是角色功能、情感功能和抑郁。EORTC QLQ-C30到PROMIS总体健康、总体QoL和焦虑评分的精度最低。几乎所有的ICC都高于0.70,EORTC QLQ-C30到PROMIS焦虑/抑郁以及PROMIS到EORTC社会功能的ICC除外。

结论

我们为EORTC QLQ-C30和PROMIS的多个量表建立了有效的转换关系。已建立的一致性表格可用于双向转换分数,并且对组水平分析有效。从EORTC情感功能到PROMIS焦虑和抑郁的转换关系表现欠佳,因此应谨慎使用。

相似文献

1
Development and validation of crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/quality of life scales and their corresponding PROMIS scales.欧洲癌症研究与治疗组织(EORTC)QLQ - C30身体、角色、社会和情感功能、疲劳及总体健康状况/生活质量量表与相应的患者报告结果测量信息系统(PROMIS)量表之间的转换关系的建立与验证。
J Clin Epidemiol. 2025 May 29;184:111853. doi: 10.1016/j.jclinepi.2025.111853.
2
Health-Related Quality of Life in Chemotherapy Patients Using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30): A Single-Institution-Based Study From Lahore, Pakistan.使用欧洲癌症研究与治疗组织生活质量问卷核心30(EORTC QLQ-C30)评估化疗患者的健康相关生活质量:来自巴基斯坦拉合尔的单机构研究。
Cureus. 2025 Jun 23;17(6):e86627. doi: 10.7759/cureus.86627. eCollection 2025 Jun.
3
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial.复发或难治性多发性骨髓瘤患者中,贝兰他单抗马福多汀、硼替佐米与地塞米松联合用药对比达雷妥尤单抗、硼替佐米与地塞米松联合用药的患者报告结局(DREAMM-7):一项3期、开放标签、随机对照试验的结果
Lancet Haematol. 2025 Jul 15. doi: 10.1016/S2352-3026(25)00163-2.
4
A Comprehensive Analysis of the Association Between the EORTC QLQ-C30 Questionnaire and Cachexia in Patients With Gastric Cancer.欧洲癌症研究与治疗组织核心生活质量问卷C30与胃癌患者恶病质相关性的综合分析
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13859. doi: 10.1002/jcsm.13859.
5
Home-based multidimensional survivorship programmes for breast cancer survivors.针对乳腺癌幸存者的居家多维康复计划。
Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD011152. doi: 10.1002/14651858.CD011152.pub2.
6
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.一般人群 EORTC QLQ-C30 量表的常模值,按年龄、性别和健康状况分组,针对法国一般人群。
J Patient Rep Outcomes. 2024 May 2;8(1):48. doi: 10.1186/s41687-024-00719-7.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Mapping and Linking between the EQ-5D-5L and the PROMIS Domains in the United States.美国EQ-5D-5L与患者报告结果测量信息系统(PROMIS)领域之间的映射与关联
Med Decis Making. 2025 Aug;45(6):740-752. doi: 10.1177/0272989X251340990. Epub 2025 Jun 13.
9
Cardiovascular training for fatigue in people with cancer.针对癌症患者疲劳问题的心血管训练
Cochrane Database Syst Rev. 2025 Feb 20;2(2):CD015517. doi: 10.1002/14651858.CD015517.
10
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®).确定患者报告的不良事件通用术语标准(PRO-CTCAE®)中恶化情况的有意义的个体水平变化阈值。
Qual Life Res. 2025 Feb;34(2):495-507. doi: 10.1007/s11136-024-03819-5. Epub 2024 Nov 6.

引用本文的文献

1
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.评估移植和CAR-T治疗受者的生活质量及症状:美国血液和骨髓移植学会(ASTCT)生存特别兴趣小组的专家小组建议
Transplant Cell Ther. 2025 Jul 1. doi: 10.1016/j.jtct.2025.06.030.